Categorized | Stock Profiles

CLSH (CLS Holdings USA Inc.)

Share Button

clhs logoCLS Holdings USA Inc. (CLSH) is a Colorado based diversified cannabis company who specializes in the extraction and conversion of cannabinoids for use of oil, wax, edibles, and shatter.

Currently, the cannabinoid makeup of cannabis plants significantly vary from grower-to-grower therefore the products generated by most extractors will vary based on the source of the plant. Aiming to produce a consistent product regardless of the grower,CLSH is utilizing a patent pending proprietary extraction and conversion method that will not only create consistency among brands, but will also surpass the current standard in the marijuana extraction industry through a different method.

By utilizing the entire plantversus processing only the bud and trim as current companies do,advanced internal testing by CLSH has concluded that a higher quality, pharmaceutical grade product with a significantly higher yield is generated. The trimming process often damages some of the crystals present on the plants and reduces the levelsof the plant’s primary psychoactive ingredient, THC, therefore, by utilizing the entire plant, CLSH is eliminating the loss of crystals and reducing the grower’s cost to trim or prepare by 18% – 22%.

The sophistication of the company’s proprietary process and planned labs will additionally allow CLSH to analyze, break down, and mix various cannabinoid extracts and levels to create a clean, safe, and consistent product that will do additional testing than the required state or industry standard to identify any harmful contaminates and by-products from certain fertilizers. Furthermore, the company has a multi-state business plan to offer companies a “one-stop-shop” facility where processing, packaging, and labeling services will be offered as laws currently prohibit the transportation of marijuana across state lines. Coinciding with this plan, CLSH recently Received its Certificate of Occupancy for a grow in Denver, Colorado to demonstrate its technology.




Market Outlook:

  • 23 states and the District of Columbia currently have laws that legalize some form of marijuana.
  • In the state of Alaska, an ounce of marijuana and six plants are permitted to be purchased, transported, or in possession.
  • The state of Georgia, residents are permitted to have up to 20 ounces of cannabis oil in possession.
  • The cannabinoid market is estimated to total $30- $50 billion however, based on the Federal Medical Cannabis Program, internal estimates believe the market will actually be worth $74 billion in 2017.
  • Cannabinoids have been found to aid migraine headaches, insomnia, depression, seizures, chronic heartburn, AIDS/HIV, Alzheimer, asthma, autoimmune disease, cancer, Crohn’s Disease, Diabetes, Glaucoma, high blood pressure, multiple sclerosism pain management, and Tourette syndrome.
  • Currently the U.S. medical and recreational marijuana market is valued at $21 billion however, if all 50 states legalized marijuana it could become larger than the $45 billion organic food industry.
  • According to the ArcView Group, a cannabis industry investment and research firm, he legal retail and wholesale cannabis sales from 2013 and 2014 increased 74% from $1.5 billion to $2.7 billion and will possibly increase another 33% to $3.5 billion by the end of 2015.
  • Market analysts predict cannabis sales have the potential to total between $7.4 – $8.2 billion by 2018 while others forecast the industry will see $10.2 billion in sales by 2019.


Recent News:

This post was written by:

- who has written 2169 posts on StockRockandRoll.

Contact the author

Comments are closed.

© 2020 MJ Capital, LLC | All rights reserved